Kevin works on the BIOS-SCOPE project with Rachel Parson, Leocadio Blanco-Bercial, and Amy Maas, where he is in charges of extracting and processing nucleic acids from zooplankton and microbial samples collected during BATS and Devil’s Hole cruises. Currently, he also optimizes the protocol for measuring ammonium in the water column, quantifies bacteria, and assists sampling during BATS and Devil’s Hole cruises.
Kevin completed his B.Sc. in biochemistry at University of Essex (England) in 2012 and obtained an M.Sc. degree in biochemistry at the University of Victoria (Canada) in 2017. His thesis focused on developing a nucleic acid-based drug for a rare eye disease called Aniridia. Post degree, Kevin worked in several laboratories to expand his molecular toolset. He determined how interferon-gamma signalling affects the functionality of a diabetic brain. He also optimized a novel genetic tool for a biotech company to detect the disease sepsis. Whilst working on these projects, he became interested in using his molecular experience in the context of environmental biology. He started working on projects that examined how the genetic difference in marine zooplankton diet may relate to various oceanographic conditions and determined the microbial and archaeal species’ contribution to the ammonification of the ocean. Before starting at BIOS, he worked as a bioinformatician characterizing epigenetic markers in salmonid genomes and their effect on gene expression.